Sharlaa Badal-Faesen
Overview
Explore the profile of Sharlaa Badal-Faesen including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
38
Citations
292
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Garrett N, Tapley A, Hudson A, Dadabhai S, Zhang B, Mgodi N, et al.
EClinicalMedicine
. 2025 Feb;
80:103054.
PMID: 39902315
Background: With limited access to mRNA COVID-19 vaccines in lower income countries, and people living with HIV (PLWH) largely excluded from clinical trials, Part A of the multicentre CoVPN 3008...
2.
Mngqibisa R, Chen H, Godfrey C, Sebitloane M, Chakalisa U, Badal-Faesen S, et al.
AIDS Res Ther
. 2024 Dec;
21(1):101.
PMID: 39736742
Background: Cervical cancer is a common cancer worldwide, with > 85% of deaths occurring in Lower- and Middle-Income Countries where resources for screening programs are limited. Women living with HIV...
3.
Garrett N, Reddy T, Yende-Zuma N, Takalani A, Woeber K, Bodenstein A, et al.
PLOS Glob Public Health
. 2024 Dec;
4(12):e0003260.
PMID: 39636838
Limited studies have been conducted on the safety and effectiveness of heterologous COVID-19 vaccine boosting in lower income settings, especially those with high-HIV prevalence., The Sisonke Heterologous mRNA-1273 boost after...
4.
Agyemang N, Scarsi K, Baker P, Smeaton L, Podany A, Olefsky M, et al.
Pharmacogenet Genomics
. 2023 Jun;
33(6):126-135.
PMID: 37306344
Objective: In AIDS Clinical Trials Group study A5375, a pharmacokinetic trial of levonorgestrel emergency contraception, double-dose levonorgestrel (3 mg, versus standard dose 1.5 mg) offset the induction effects of efavirenz...
5.
Araujo-Pereira M, Krishnan S, Salgame P, Manabe Y, Hosseinipour M, Bisson G, et al.
EClinicalMedicine
. 2023 Jun;
60:102030.
PMID: 37287871
Background: Tuberculosis (TB) is an infectious morbidity that commonly occurs in people living with HIV (PWH) and increases the progression of HIV disease, as well as the risk of death....
6.
Lundgren J, Babiker A, Sharma S, Grund B, Phillips A, Matthews G, et al.
NEJM Evid
. 2023 May;
2(3).
PMID: 37213438
Background: For people with HIV and CD4 counts >500 cells/mm, early initiation of antiretroviral therapy (ART) reduces serious AIDS and serious non-AIDS (SNA) risk compared with deferral of treatment until...
7.
Kim S, Hesseling A, Wu X, Hughes M, Shah N, Gaikwad S, et al.
PLoS One
. 2023 Mar;
18(3):e0283290.
PMID: 36930628
Background: Understanding factors associated with prevalent Mycobacterium tuberculosis infection and prevalent TB disease in household contacts of patients with drug-resistant tuberculosis (TB) may be useful for TB program staff conducting...
8.
Kurbatova E, Phillips P, Dorman S, Sizemore E, Bryant K, Purfield A, et al.
Am J Respir Crit Care Med
. 2023 Feb;
207(10):1376-1382.
PMID: 36790881
We developed a standardized method, possible poor treatment response (PPTR), to help ascertain efficacy endpoints in Study S31/A5349 (NCT02410772), an open-label trial comparing two 4-month rifapentine-based regimens with a standard...
9.
Lalloo U, Komarow L, Aberg J, Clifford D, Hogg E, McKhann A, et al.
PLoS One
. 2023 Feb;
18(2):e0281580.
PMID: 36780493
Background: The WHO recommended 1200mg/day of fluconazole (FCZ) in the induction phase of cryptococcal meningitis (CM) in HIV prior to 2018 in regions where amphotericin-B (AMB) was unavailable. A 2-stage...
10.
Scarsi K, Smeaton L, Podany A, Olefsky M, Woolley E, Barr E, et al.
Contraception
. 2023 Jan;
121:109951.
PMID: 36641094
Objectives: To determine if double-dose levonorgestrel emergency contraception (EC) in combination with efavirenz or rifampicin, 2 drugs known to decrease levonorgestrel exposure, resulted in similar pharmacokinetics compared to standard-dose levonorgestrel...